Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Adrenocortical carcinoma: a comprehensive immunohistochemical study of 40 cases.

Weissferdt A, Phan A, Suster S, Moran CA.

Appl Immunohistochem Mol Morphol. 2014 Jan;22(1):24-30. doi: 10.1097/PAI.0b013e31828a96cf.

PMID:
23531850
2.

Myxoid adrenocortical carcinoma: a clinicopathologic and immunohistochemical study of 7 cases, including 1 case with lipomatous metaplasia.

Weissferdt A, Phan A, Suster S, Moran CA.

Am J Clin Pathol. 2013 Jun;139(6):780-6. doi: 10.1309/AJCPCDZLC13RSXRZ.

3.

Immunohistochemical distinction of metastases of renal cell carcinoma to the adrenal from primary adrenal nodules, including oncocytic tumor.

Li H, Hes O, MacLennan GT, Eastwood DC, Iczkowski KA.

Virchows Arch. 2015 May;466(5):581-8. doi: 10.1007/s00428-015-1732-9. Epub 2015 Feb 19.

PMID:
25690138
4.
5.
6.
7.
8.

Comparison of immunohistochemical markers in the differential diagnosis of adrenocortical tumors: immunohistochemical analysis of adrenocortical tumors.

Zhang H, Bu H, Chen H, Wei B, Liu W, Guo J, Li F, Liao D, Tang Y, Zhang Z.

Appl Immunohistochem Mol Morphol. 2008 Jan;16(1):32-9.

PMID:
18091323
9.

Immunohistochemical distinction of primary adrenal cortical lesions from metastatic clear cell renal cell carcinoma: a study of 248 cases.

Sangoi AR, Fujiwara M, West RB, Montgomery KD, Bonventre JV, Higgins JP, Rouse RV, Gokden N, McKenney JK.

Am J Surg Pathol. 2011 May;35(5):678-86. doi: 10.1097/PAS.0b013e3182152629.

11.

Primary rhabdoid adrenocortical carcinoma: a clinicopathological and immunohistochemical study of three cases.

Weissferdt A, Phan A, Suster S, Moran CA.

Histopathology. 2013 Apr;62(5):771-7. doi: 10.1111/his.12083. Epub 2013 Feb 28.

PMID:
23445527
12.

Calretinin and inhibin are useful in separating adrenocortical neoplasms from pheochromocytomas.

Jorda M, De MB, Nadji M.

Appl Immunohistochem Mol Morphol. 2002 Mar;10(1):67-70.

PMID:
11893039
13.

[Diagnostic value of A103 and inhibin-alpha in adrenocortical tumors: an immunohistochemical study using tissue microarray techniques].

Zhang HY, Wang XJ, Liu WP, Jiang LL, Li GD, Guo J, Zhang YH.

Zhonghua Bing Li Xue Za Zhi. 2004 Jun;33(3):203-7. Chinese.

PMID:
15256108
14.

Adrenocortical carcinoma. An immunohistochemical comparison with renal cell carcinoma.

Wick MR, Cherwitz DL, McGlennen RC, Dehner LP.

Am J Pathol. 1986 Feb;122(2):343-52.

15.

Immunohistochemical study of adrenocortical carcinoma. Predictive value of the D11 monoclonal antibody.

Tartour E, Caillou B, Tenenbaum F, Schröder S, Luciani S, Talbot M, Schlumberger M.

Cancer. 1993 Dec 1;72(11):3296-303.

16.

Sertoli cell tumors of the ovary: a clinicopathologic and immunohistochemical study of 54 cases.

Oliva E, Alvarez T, Young RH.

Am J Surg Pathol. 2005 Feb;29(2):143-56.

PMID:
15644771
18.

Ovarian steroid cell tumors: an immunohistochemical study including a comparison of calretinin with inhibin.

Deavers MT, Malpica A, Ordonez NG, Silva EG.

Int J Gynecol Pathol. 2003 Apr;22(2):162-7.

PMID:
12649671
20.

Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas.

Hofland J, Feelders RA, van der Wal R, Kerstens MN, Haak HR, de Herder WW, de Jong FH.

Eur J Endocrinol. 2012 Feb;166(2):281-9. doi: 10.1530/EJE-11-0693. Epub 2011 Nov 29.

Items per page

Supplemental Content

Write to the Help Desk